The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD

N. S. Pauwels, K. R. Bracke, T. Maes, G. F. Joos, G. G. Brusselle (Ghent, Belgium)

Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Session: Best of lung epithelial cells 2008
Session type: Oral Presentation
Number: 1760
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. S. Pauwels, K. R. Bracke, T. Maes, G. F. Joos, G. G. Brusselle (Ghent, Belgium). The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD. Eur Respir J 2008; 32: Suppl. 52, 1760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Rene Hummel - 29.10.2008 14:46
Mr Rene Hummel
Hi I am very interested in your Poster and hoped that you could email me a version of it. Regards Rene' Hummel. Neurosearch. Email: rhu@neurosearch.dk
You must Login to comment this presentation.


Related content which might interest you:
The role of leptin in pulmonary neutrophilia during murine acute lung injury
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011

Characterisation of endogenous IL-33 using a model of Alternaria-induced pulmonary inflammation
Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways
Year: 2012


Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

Hyperhomocysteinemia promotes pulmonary emphysema in murine model of COPD
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

Systemic inflammation in COPD – a role for infection?
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006


Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014



Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 122s
Year: 2003

Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016


IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006